ALL (Acute Lymphoblastic Leukemia)

Conference Coverage

Prognostic features could improve ALL outcomes

CHICAGO – Cytogenetic factors, minimal residual disease activity, and Philadelphia chromosome–like signature are among the features with...


From the Journals

Kymriah appears cost effective in analysis

The latest study on the CAR T therapy tisagenlecleucel for pediatric leukemia says it may be cost effective, provided that the long-term benefits...